Skip to content

Join us at this webinar you will hear from our 3 panelists discuss regulatory, technology and scientific perspectives to gain insights, into accelerating your compound through the clinical development pipeline with a focus on retina.

Reducing compound attrition by predicting renal tubular toxicity with in vitro PTEC models


September 1, 2020

Presented by

Dr Piyush Bajaj & Dr Colin Brown

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

Get our latest updates straight to your inbox